title: Iron-ascorbate-phospholipid mediated modification of low density lipoprotein.
abstract: LDL can be oxidized by a variety of agents to form a modified lipoprotein which is capable of being avidly metabolized by macrophages. While previous in vitro studies have focused exclusively on the oxidation of LDL, other lipids found in the atheroma are also subject to oxidation and its lipoperoxide byproducts may contribute to the process of LDL modification. To examine the relationship between the oxidation of phospholipids and the subsequent modification of LDL, we incubated 250 microM phosphatidylcholine with 10 microM ferrous sulfate and 50 microM ascorbic acid in 10 mM Tris (pH 7.0). After 18 h at 37 degrees C, significant amounts of thiobarbituric acid reactive substances (TBARS) were formed. The inclusion of LDL (100 micrograms protein/ml) elevated the TBARS and increased the electrophoretic mobility of the lipoprotein. LDL treated with iron and ascorbate in the absence of phosphatidylcholine did not result in the modification of this lipoprotein. LDL that was incubated with phosphatidylcholine, iron and ascorbate was found to be metabolized by macrophages to a far greater extent than native LDL or LDL treated with phosphatidylcholine alone. Probucol (10 microM) inhibited the LDL modification process. These results demonstrate that while iron and ascorbate cannot oxidize LDL directly, the addition of phosphatidylcholine to these initiators of lipid peroxidation can mediate and lead to the modification of LDL.
authors.affiliation: Department of Pharmacology and Toxicology, School of Pharmacy, University of Georgia, Athens 30602, USA.
authors.forename: P
authors.initials: P
authors.lastname: Greenspan
authors.forename: H
authors.initials: H
authors.lastname: Yu
authors.forename: R L
authors.initials: RL
authors.lastname: Gutman
authors.forename: F
authors.initials: F
authors.lastname: Mao
authors.forename: B H
authors.initials: BH
authors.lastname: Ryu
authors.forename: P
authors.initials: P
authors.lastname: Lou
mesh_terms: D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology*; D005260:Female; D005296:Ferrous Compounds / Q000494:pharmacology*; D015227:Lipid Peroxidation / Q000187:drug effects*; D008077:Lipoproteins, LDL / Q000378:metabolism*; D008081:Liposomes; D017737:Macrophages, Peritoneal / Q000378:metabolism; D051379:Mice; D008813:Mice, Inbred ICR; D010713:Phosphatidylcholines / Q000494:pharmacology*; D017392:Thiobarbituric Acid Reactive Substances / Q000378:metabolism
chemical_list: D005296:Ferrous Compounds; D008077:Lipoproteins, LDL; D008081:Liposomes; D010713:Phosphatidylcholines; D017392:Thiobarbituric Acid Reactive Substances; C020748:ferrous sulfate; D001205:Ascorbic Acid